Similar articles

• [Mycoses and their treatment in malignant hemopathies].

  Martino P, Girmenia C. Martino P, et al. Recenti Prog Med. 1999 Mar;90(3):160-8. Recenti Prog Med. 1999. PMID: 10228357 Review. Italian.
• Considerations in the approach to invasive fungal infection in patients with haematological malignancies.

  Bow EJ. Bow EJ. Br J Haematol. 2008 Jan;140(2):133-52. doi: 10.1111/j.1365-2141.2007.06906.x. Br J Haematol. 2008. PMID: 18173752 Review.
• Antifungal therapy in 'bone marrow failure'.

  Richardson MD, Kokki MH. Richardson MD, et al. Br J Haematol. 1998 Mar;100(4):619-28. doi: 10.1046/j.1365-2141.1998.00600.x. Br J Haematol. 1998. PMID: 9531326 Review. No abstract available.
• Fungal infection from Fusarium spp. in children with refractory hematologic malignancies.

  Taçyildiz N, Yavuz G, Unal E, Gözdasoğlu S, Ertem M, Aysev D. Taçyildiz N, et al. Med Pediatr Oncol. 1999 Dec;33(6):596-7. doi: 10.1002/(sici)1096-911x(199912)33:6<596::aid-mpo17>3.0.co;2-i. Med Pediatr Oncol. 1999. PMID: 10573590 No abstract available.
• Fungal infections in nontransplant patients with hematologic malignancies.

  Segal BH, Bow EJ, Menichetti F. Segal BH, et al. Infect Dis Clin North Am. 2002 Dec;16(4):935-64, vii. doi: 10.1016/s0891-5520(02)00043-0. Infect Dis Clin North Am. 2002. PMID: 12512188 Review.